Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2002 Jan;39(1):1–5. doi: 10.1136/jmg.39.1.1

Familial adult renal neoplasia

M Takahashi 1, R Kahnoski 1, D Gross 1, D Nicol 1, B Teh 1
PMCID: PMC1734964  PMID: 11826016

Full Text

The Full Text of this article is available as a PDF (102.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amin M. B., Corless C. L., Renshaw A. A., Tickoo S. K., Kubus J., Schultz D. S. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997 Jun;21(6):621–635. doi: 10.1097/00000478-199706000-00001. [DOI] [PubMed] [Google Scholar]
  2. Birt A. R., Hogg G. R., Dubé W. J. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977 Dec;113(12):1674–1677. [PubMed] [Google Scholar]
  3. Bodmer D., Eleveld M. J., Ligtenberg M. J., Weterman M. A., Janssen B. A., Smeets D. F., de Wit P. E., van den Berg A., van den Berg E., Koolen M. I. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation. Am J Hum Genet. 1998 Jun;62(6):1475–1483. doi: 10.1086/301888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brauch H., Weirich G., Brieger J., Glavac D., Rödl H., Eichinger M., Feurer M., Weidt E., Puranakanitstha C., Neuhaus C. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 2000 Apr 1;60(7):1942–1948. [PubMed] [Google Scholar]
  5. Chung J. Y., Ramos-Caro F. A., Beers B., Ford M. J., Flowers F. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol. 1996 May;35(5):365–367. doi: 10.1111/j.1365-4362.1996.tb03642.x. [DOI] [PubMed] [Google Scholar]
  6. Cohen A. J., Li F. P., Berg S., Marchetto D. J., Tsai S., Jacobs S. C., Brown R. S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979 Sep 13;301(11):592–595. doi: 10.1056/NEJM197909133011107. [DOI] [PubMed] [Google Scholar]
  7. Cook J. A., Oliver K., Mueller R. F., Sampson J. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet. 1996 Jun;33(6):480–484. doi: 10.1136/jmg.33.6.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Delahunt B., Eble J. N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997 Jun;10(6):537–544. [PubMed] [Google Scholar]
  9. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  10. Foucar K., Rosen T., Foucar E., Cochran R. J. Fibrofolliculoma: a clinicopathologic study. Cutis. 1981 Oct;28(4):429–432. [PubMed] [Google Scholar]
  11. Friedrich C. A. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet. 2001 Apr;10(7):763–767. doi: 10.1093/hmg/10.7.763. [DOI] [PubMed] [Google Scholar]
  12. Fryer A. E., Chalmers A., Connor J. M., Fraser I., Povey S., Yates A. D., Yates J. R., Osborne J. P. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet. 1987 Mar 21;1(8534):659–661. doi: 10.1016/s0140-6736(87)90416-8. [DOI] [PubMed] [Google Scholar]
  13. Gemmill R. M., West J. D., Boldog F., Tanaka N., Robinson L. J., Smith D. I., Li F., Drabkin H. A. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9572–9577. doi: 10.1073/pnas.95.16.9572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gnarra J. R., Tory K., Weng Y., Schmidt L., Wei M. H., Li H., Latif F., Liu S., Chen F., Duh F. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994 May;7(1):85–90. doi: 10.1038/ng0594-85. [DOI] [PubMed] [Google Scholar]
  15. Gomez M. R. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N Y Acad Sci. 1991;615:1–7. doi: 10.1111/j.1749-6632.1991.tb37742.x. [DOI] [PubMed] [Google Scholar]
  16. Haimowitz J. E., Halpern A. C., Heymann W. R. Multiple, hereditary dome-shaped papules and acrochordons. Birt-Hogg-Dubé syndrome. Arch Dermatol. 1997 Sep;133(9):1163–1166. doi: 10.1001/archderm.133.9.1163. [DOI] [PubMed] [Google Scholar]
  17. Haven C. J., Wong F. K., van Dam E. W., van der Juijt R., van Asperen C., Jansen J., Rosenberg C., de Wit M., Roijers J., Hoppener J. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab. 2000 Apr;85(4):1449–1454. doi: 10.1210/jcem.85.4.6518. [DOI] [PubMed] [Google Scholar]
  18. Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., Linehan W. M. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700–9704. doi: 10.1073/pnas.91.21.9700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Iliopoulos O., Levy A. P., Jiang C., Kaelin W. G., Jr, Goldberg M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10595–10599. doi: 10.1073/pnas.93.20.10595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jeffers M., Schmidt L., Nakaigawa N., Webb C. P., Weirich G., Kishida T., Zbar B., Vande Woude G. F. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11445–11450. doi: 10.1073/pnas.94.21.11445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kamura T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R. C., Conaway J. W. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10430–10435. doi: 10.1073/pnas.190332597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kanayama H., Lui W. O., Takahashi M., Naroda T., Kedra D., Wong F. K., Kuroki Y., Nakahori Y., Larsson C., Kagawa S. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. J Med Genet. 2001 Mar;38(3):165–170. doi: 10.1136/jmg.38.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kandt R. S., Haines J. L., Smith M., Northrup H., Gardner R. J., Short M. P., Dumars K., Roach E. S., Steingold S., Wall S. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet. 1992 Sep;2(1):37–41. doi: 10.1038/ng0992-37. [DOI] [PubMed] [Google Scholar]
  24. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res. 1993;62:89–124. doi: 10.1016/s0065-230x(08)60316-4. [DOI] [PubMed] [Google Scholar]
  25. Lamb R. F., Roy C., Diefenbach T. J., Vinters H. V., Johnson M. W., Jay D. G., Hall A. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol. 2000 May;2(5):281–287. doi: 10.1038/35010550. [DOI] [PubMed] [Google Scholar]
  26. Latif F., Tory K., Gnarra J., Yao M., Duh F. M., Orcutt M. L., Stackhouse T., Kuzmin I., Modi W., Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993 May 28;260(5112):1317–1320. doi: 10.1126/science.8493574. [DOI] [PubMed] [Google Scholar]
  27. Launonen V., Vierimaa O., Kiuru M., Isola J., Roth S., Pukkala E., Sistonen P., Herva R., Aaltonen L. A. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001 Feb 27;98(6):3387–3392. doi: 10.1073/pnas.051633798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lynch H. T., de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999 Nov;36(11):801–818. [PMC free article] [PubMed] [Google Scholar]
  29. Maher E. R., Kaelin W. G., Jr von Hippel-Lindau disease. Medicine (Baltimore) 1997 Nov;76(6):381–391. doi: 10.1097/00005792-199711000-00001. [DOI] [PubMed] [Google Scholar]
  30. Malchoff C. D., Sarfarazi M., Tendler B., Forouhar F., Whalen G., Joshi V., Arnold A., Malchoff D. M. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab. 2000 May;85(5):1758–1764. doi: 10.1210/jcem.85.5.6557. [DOI] [PubMed] [Google Scholar]
  31. Maxwell P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E., Wykoff C. C., Pugh C. W., Maher E. R., Ratcliffe P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999 May 20;399(6733):271–275. doi: 10.1038/20459. [DOI] [PubMed] [Google Scholar]
  32. Meloni A. M., Bridge J., Sandberg A. A. Reviews on chromosome studies in urological tumors. I. Renal tumors. J Urol. 1992 Aug;148(2 Pt 1):253–265. doi: 10.1016/s0022-5347(17)36565-5. [DOI] [PubMed] [Google Scholar]
  33. Moch H., Gasser T., Amin M. B., Torhorst J., Sauter G., Mihatsch M. J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000 Aug 1;89(3):604–614. [PubMed] [Google Scholar]
  34. Moreno A., Puig L., de Moragas J. M. Multiple fibrofolliculomas and trichodiscomas. Dermatologica. 1985;171(5):338–342. doi: 10.1159/000249448. [DOI] [PubMed] [Google Scholar]
  35. Ohh M., Park C. W., Ivan M., Hoffman M. A., Kim T. Y., Huang L. E., Pavletich N., Chau V., Kaelin W. G. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000 Jul;2(7):423–427. doi: 10.1038/35017054. [DOI] [PubMed] [Google Scholar]
  36. Ohta M., Inoue H., Cotticelli M. G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996 Feb 23;84(4):587–597. doi: 10.1016/s0092-8674(00)81034-x. [DOI] [PubMed] [Google Scholar]
  37. Rongioletti F., Hazini R., Gianotti G., Rebora A. Fibrofolliculomas, tricodiscomas and acrochordons (Birt-Hogg-Dubé) associated with intestinal polyposis. Clin Exp Dermatol. 1989 Jan;14(1):72–74. doi: 10.1111/j.1365-2230.1989.tb00890.x. [DOI] [PubMed] [Google Scholar]
  38. Roth J. S., Rabinowitz A. D., Benson M., Grossman M. E. Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol. 1993 Dec;29(6):1055–1056. doi: 10.1016/s0190-9622(08)82049-x. [DOI] [PubMed] [Google Scholar]
  39. Sampson J. R., Patel A., Mee A. D. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J Med Genet. 1995 Nov;32(11):848–850. doi: 10.1136/jmg.32.11.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schmidt L., Duh F. M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S. W., Zhuang Z., Lubensky I., Dean M. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 1997 May;16(1):68–73. doi: 10.1038/ng0597-68. [DOI] [PubMed] [Google Scholar]
  41. Schmidt L., Junker K., Weirich G., Glenn G., Choyke P., Lubensky I., Zhuang Z., Jeffers M., Vande Woude G., Neumann H. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res. 1998 Apr 15;58(8):1719–1722. [PubMed] [Google Scholar]
  42. Schmidt L., Li F., Brown R. S., Berg S., Chen F., Wei M. H., Tory K., Lerman I., Zbar B. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am. 1995 Sep-Oct;1(3):191–195. [PubMed] [Google Scholar]
  43. Soucek T., Pusch O., Wienecke R., DeClue J. E., Hengstschläger M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem. 1997 Nov 14;272(46):29301–29308. doi: 10.1074/jbc.272.46.29301. [DOI] [PubMed] [Google Scholar]
  44. Starink T. M., Brownstein M. H. Fibrofolliculoma: solitary and multiple types. J Am Acad Dermatol. 1987 Sep;17(3):493–496. doi: 10.1016/s0190-9622(87)70235-7. [DOI] [PubMed] [Google Scholar]
  45. Starink T. M., Kisch L. S., Meijer C. J. Familial multiple trichodiscomas. A clinicopathologic study. Arch Dermatol. 1985 Jul;121(7):888–891. [PubMed] [Google Scholar]
  46. Störkel S., Eble J. N., Adlakha K., Amin M., Blute M. L., Bostwick D. G., Darson M., Delahunt B., Iczkowski K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997 Sep 1;80(5):987–989. doi: 10.1002/(sici)1097-0142(19970901)80:5<987::aid-cncr24>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  47. Szabó J., Heath B., Hill V. M., Jackson C. E., Zarbo R. J., Mallette L. E., Chew S. L., Besser G. M., Thakker R. V., Huff V. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet. 1995 Apr;56(4):944–950. [PMC free article] [PubMed] [Google Scholar]
  48. Teh B. T., Blennow E., Giraud S., Sahlén S., Hii S. I., Brookwell R., Brauch H., Nordenskjöld M., Larsson C., Nicol D. Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution. Genes Chromosomes Cancer. 1998 Mar;21(3):260–264. doi: 10.1002/(sici)1098-2264(199803)21:3<260::aid-gcc12>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  49. Teh B. T., Farnebo F., Kristoffersson U., Sundelin B., Cardinal J., Axelson R., Yap A., Epstein M., Heath H., 3rd, Cameron D. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab. 1996 Dec;81(12):4204–4211. doi: 10.1210/jcem.81.12.8954016. [DOI] [PubMed] [Google Scholar]
  50. Teh B. T., Giraud S., Sari N. F., Hii S. I., Bergerat J. P., Larsson C., Limacher J. M., Nicol D. Familial non-VHL non-papillary clear-cell renal cancer. Lancet. 1997 Mar 22;349(9055):848–849. doi: 10.1016/S0140-6736(05)61751-5. [DOI] [PubMed] [Google Scholar]
  51. Toro J. R., Glenn G., Duray P., Darling T., Weirich G., Zbar B., Linehan M., Turner M. L. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. Arch Dermatol. 1999 Oct;135(10):1195–1202. doi: 10.1001/archderm.135.10.1195. [DOI] [PubMed] [Google Scholar]
  52. Webster A. R., Richards F. M., MacRonald F. E., Moore A. T., Maher E. R. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet. 1998 Oct;63(4):1025–1035. doi: 10.1086/302037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Weirich G., Glenn G., Junker K., Merino M., Störkel S., Lubensky I., Choyke P., Pack S., Amin M., Walther M. M. Familial renal oncocytoma: clinicopathological study of 5 families. J Urol. 1998 Aug;160(2):335–340. doi: 10.1016/s0022-5347(01)62888-x. [DOI] [PubMed] [Google Scholar]
  54. Woodward E. R., Clifford S. C., Astuti D., Affara N. A., Maher E. R. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes. J Med Genet. 2000 May;37(5):348–353. doi: 10.1136/jmg.37.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zbar B., Glenn G., Lubensky I., Choyke P., Walther M. M., Magnusson G., Bergerheim U. S., Pettersson S., Amin M., Hurley K. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol. 1995 Mar;153(3 Pt 2):907–912. [PubMed] [Google Scholar]
  56. Zhuang Z., Park W. S., Pack S., Schmidt L., Vortmeyer A. O., Pak E., Pham T., Weil R. J., Candidus S., Lubensky I. A. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet. 1998 Sep;20(1):66–69. doi: 10.1038/1727. [DOI] [PubMed] [Google Scholar]
  57. van Kessel A. G., Wijnhoven H., Bodmer D., Eleveld M., Kiemeney L., Mulders P., Weterman M., Ligtenberg M., Smeets D., Smits A. Renal cell cancer: chromosome 3 translocations as risk factors. J Natl Cancer Inst. 1999 Jul 7;91(13):1159–1160. doi: 10.1093/jnci/91.13.1159. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES